Summary
- Current Price
- As of today, AARD price is $6.11, up +6.82% on
- Current Price All-Time High
- AARD price is currently -68.79% below its historical high of $19.58 set on
- Market Cap
- AARD current market cap is $133M, down -43.97% year-over-year
- PE Ratio
- AARD PE ratio is unknown
- Revenue
- AARD current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AARD is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aardvark Therapeutics, Inc. |
| Ticker | NASDAQ: AARD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aardvarktherapeutics.com |
| Employees | 26 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $6.11 | ||
| Price, 1D Change | +6.82% | |
| $133M | ||
| - | ||
| - | ||
| 2.08 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.64 | ||
| EPS, 1Y Change | -178.21% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.64 | ||
| EPS Estimate | N/A | -$3.78 |
| EPS Est. Change | N/A | -43.00% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $6.11 | ||
| Price Target | - | $13.50 |
| Price Tgt. Change | - | +120.95% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.58 | -$0.95 | -63.60% | |
| -$2.94 | -$2.64 | +10.21% | |
| -$3.78 | N/A | -43.00% | |
| -$3.28 | N/A | -24.06% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -44.30% | ||
| - | ||
| -43.97% | ||
| - | ||
| 0.00% | ||
| 0.00% | ||
| -178.21% | ||
| -316.19% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $6.11 | ||
| $10.33 | ||
| SMA 200 vs Price | +69.11% | |
| $4.92 | ||
| SMA 50 vs Price | -19.40% | |
| 2.08 | ||
| $0.44 | ||
| 60.44 | ||
| 82.82% | ||
| 107.77% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.64 | ||
| -$36.00K | ||
| - | ||
| -$62.73M | ||
| - | ||
| -$57.59M | ||
| - | ||
| -$62.69M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 10.61 | ||
| 10.61 | ||
| - | ||
| - | ||
| 5.47 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.53 | ||
| -0.57 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $106.63M | ||
| $110.03M | ||
| $117.18M | ||
| $111.89M | ||
| $10.55M | ||
| $10.55M | ||
| $441.00K | ||
| $441.00K | ||
| $2.07M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $57.59M | ||
| $62.69M | ||
| $36.00K | ||
| $0.00 | ||
| $36.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$54.17M | ||
| -$49.67M | ||
| $89.25M | ||
| $95.00K | ||
| -$54.27M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| Stifel | → | |
| RBC Capital | → | |
| Oppenheimer | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer |
Analyst sentiment
Institutional ownership
Screeners with AARD
FAQ
What is the ticker symbol for Aardvark Therapeutics, Inc.?
The ticker symbol for Aardvark Therapeutics, Inc. is NASDAQ:AARD
Does Aardvark Therapeutics, Inc. pay dividends?
No, Aardvark Therapeutics, Inc. does not pay dividends
What sector is Aardvark Therapeutics, Inc. in?
Aardvark Therapeutics, Inc. is in the Healthcare sector
What industry is Aardvark Therapeutics, Inc. in?
Aardvark Therapeutics, Inc. is in the Biotechnology industry
What country is Aardvark Therapeutics, Inc. based in?
Aardvark Therapeutics, Inc. is headquartered in United States
When did Aardvark Therapeutics, Inc. go public?
Aardvark Therapeutics, Inc. initial public offering (IPO) was on February 13, 2025
Is Aardvark Therapeutics, Inc. in the S&P 500?
No, Aardvark Therapeutics, Inc. is not included in the S&P 500 index
Is Aardvark Therapeutics, Inc. in the NASDAQ 100?
No, Aardvark Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Aardvark Therapeutics, Inc. in the Dow Jones?
No, Aardvark Therapeutics, Inc. is not included in the Dow Jones index
When was Aardvark Therapeutics, Inc. last earnings report?
Aardvark Therapeutics, Inc.'s most recent earnings report was on November 13, 2025
When does Aardvark Therapeutics, Inc. report earnings?
The next expected earnings date for Aardvark Therapeutics, Inc. is May 14, 2026
Data Sources & References
- AARD Official Website aardvarktherapeutics.com
- AARD Profile on Yahoo Finance finance.yahoo.com/quote/AARD
- AARD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aard